Brief: Aadi Bioscience Announces Leadership Transition

Whitehawk Therapeutics

03/03/2023 14:23

March 3 (Reuters) - Aadi Bioscience Inc  AADI.O :
    * AADI BIOSCIENCE ANNOUNCES LEADERSHIP TRANSITION
    * BRENDAN DELANEY HAS RESIGNED FOR PERSONAL REASONS FROM HIS
POSITION AS CHIEF EXECUTIVE OFFICER
    * BOARD OF DIRECTORS HAS INITIATED AN EXECUTIVE SEARCH FOR A
REPLACEMENT CEO
    * BOARD OF DIRECTORS HAS INITIATED AN EXECUTIVE SEARCH FOR A
REPLACEMENT CEO
    * SCOTT GIACOBELLO HAS BEEN APPOINTED TO SERVE AS INTERIM
CHIEF
EXECUTIVE OFFICER AND PRESIDENT

Source text for Eikon:  ID:nPnND08ja 
Further company coverage:  AADI.O